Literature DB >> 14961778

Chemotherapy-related nausea and vomiting - past reflections, present practice and future management.

M Miller1, N Kearney.   

Abstract

Although much progress has occurred in the last decade regarding the management of chemotherapy-induced nausea and vomiting, these remain among the most intolerable side-effects of treatment and patients continue to report the negative impact such symptoms have on their ability to enjoy life. Inadequate control of nausea and vomiting reduces patients' quality of life and functional status and jeopardizes the delivery of optimal treatment, so making its management a priority for oncology health care workers. This article will reflect on past and present evidence regarding the management of chemotherapy-induced nausea and vomiting while highlighting some of the most recent scientific advances before drawing conclusions about the future management of this troublesome symptom for patients receiving chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961778     DOI: 10.1111/j.1365-2354.2004.00446.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  21 in total

1.  Serial overshadowing of taste aversion learning by stimuli preceding the target taste.

Authors:  Dorothy W S Kwok; Evan J Livesey; Robert A Boakes
Journal:  Learn Behav       Date:  2012-12       Impact factor: 1.986

Review 2.  A review of patient self-report tools for chemotherapy-induced nausea and vomiting.

Authors:  Sarah G Brearley; Caroline V Clements; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2008-06-13       Impact factor: 3.603

3.  Distress before chemotherapy predicts delayed but not acute nausea.

Authors:  Sara C Higgins; Guy H Montgomery; Dana H Bovbjerg
Journal:  Support Care Cancer       Date:  2006-08-03       Impact factor: 3.603

4.  Conditioned taste aversions: From poisons to pain to drugs of abuse.

Authors:  Jian-You Lin; Joe Arthurs; Steve Reilly
Journal:  Psychon Bull Rev       Date:  2017-04

5.  The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life.

Authors:  Carole Farrell; Sarah G Brearley; Mark Pilling; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2012-05-19       Impact factor: 3.603

6.  Self-reported taste and smell changes during cancer chemotherapy.

Authors:  Britt-Marie Bernhardson; Carol Tishelman; Lars E Rutqvist
Journal:  Support Care Cancer       Date:  2007-08-21       Impact factor: 3.603

7.  Patients' Perceptions of Physician-Patient Discussions and Adverse Events with Cancer Therapy.

Authors:  Dawn Hershman; Elizabeth Calhoun; Kinga Zapert; Shawn Wade; Jennifer Malin; Rich Barron
Journal:  Arch Drug Inf       Date:  2008-09

8.  Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.

Authors:  Joseph A Roscoe; Charles E Heckler; Gary R Morrow; Supriya G Mohile; Shaker R Dakhil; James L Wade; J Philip Kuebler
Journal:  J Clin Oncol       Date:  2012-08-20       Impact factor: 44.544

9.  The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California.

Authors:  Marilyn L Kwan; Christine B Ambrosone; Marion M Lee; Janice Barlow; Sarah E Krathwohl; Isaac Joshua Ergas; Christine H Ashley; Julie R Bittner; Jeanne Darbinian; Keren Stronach; Bette J Caan; Warren Davis; Susan E Kutner; Charles P Quesenberry; Carol P Somkin; Barbara Sternfeld; John K Wiencke; Shichun Zheng; Lawrence H Kushi
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

10.  Acupressure bands are effective in reducing radiation therapy-related nausea.

Authors:  Joseph A Roscoe; Peter Bushunow; Pascal Jean-Pierre; Charles E Heckler; Jason Q Purnell; Luke J Peppone; Yuhchyau Chen; Marilyn N Ling; Gary R Morrow
Journal:  J Pain Symptom Manage       Date:  2009-03-28       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.